|
| 1 |
Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy
Sang Joon Shin, Jae Lyun Lee, Tae Gyun Kwon, Byoung Young Shim, Ho Seok Chung, Sang-Hee Kim, Se Hoon Park
Cancer Res Treat.2023;55(2):643-651. Published online 2022 November 28
DOI: http://dx.doi.org/10.4143/crt.2022.883
|
|
| 2 |
Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance
Jun Sung Moon, Nam Hoon Kim, Jin Oh Na, Jae Hyoung Cho, In-Kyung Jeong, Soon Hee Lee, Ji-Oh Mok, Nan Hee Kim, Dong Jin Chung, Jinhong Cho, Dong Woo Lee, Sun Woo Lee, Kyu Chang Won
|
|
| 3 |
Real-World Safety and Effectiveness of Denosumab in Patients with Osteoporosis: A Prospective, Observational Study in South Korea
Yumie Rhee, Dong-Gune Chang, Jeonghoon Ha, Sooa Kim, Yusun Lee, Euna Jo, Jung-Min Koh
|
|
| 4 |
Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
Shiro Nakamura, Teita Asano, Hiroaki Tsuchiya, Kanami Sugimoto, Yuya Imai, Seiji Yokoyama, Yasuo Suzuki
Intest Res.2022;20(3):329-341. Published online 2021 August 4
DOI: http://dx.doi.org/10.5217/ir.2021.00032
|
|
| 5 |
Machine Learning Approach for Active Vaccine Safety Monitoring
Yujeong Kim, Jong-Hwan Jang, Namgi Park, Na-Young Jeong, Eunsun Lim, Soyun Kim, Nam-Kyong Choi, Dukyong Yoon
|
|
| 6 |
Long-term safety and effectiveness of adalimumab in Japanese patients with Crohn’s disease: 3-year results from a real-world study
Tadakazu Hisamatsu, Yasuo Suzuki, Mariko Kobayashi, Takashi Hagiwara, Takeshi Kawaberi, Haruhiko Ogata, Toshiyuki Matsui, Mamoru Watanabe, Toshifumi Hibi
Intest Res.2021;19(4):408-418. Published online 2020 November 20
DOI: http://dx.doi.org/10.5217/ir.2020.00025
|
|
| 7 |
Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
Haruhiko Ogata, Takashi Hagiwara, Takeshi Kawaberi, Mariko Kobayashi, Toshifumi Hibi
Intest Res.2021;19(4):419-429. Published online 2020 November 10
DOI: http://dx.doi.org/10.5217/ir.2020.00033
|
|
| 8 |
An Open Label, Multi-Center, Non-Interventional Post-Marketing Surveillance to Monitor the Safety and Efficacy of ALTARGO® (Retapamulin) Administered in Korean Patients According to the Prescribing Information
Woosung Hong, Yil-Seob Lee, Chun-Wook Park, Moon-Soo Yoon, Young Suck Ro
Ann Dermatol.2018;30(4):441-450. Published online 2018 June 28
DOI: http://dx.doi.org/10.5021/ad.2018.30.4.441
|
|
| 9 |
Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia
Gwang Seong Choi, Joon Hyung Kim, Shin-Young Oh, Jung-Min Park, Ji-Soo Hong, Yil-Seob Lee, Won-Soo Lee
Ann Dermatol.2016;28(4):444-450. Published online 2016 July 26
DOI: http://dx.doi.org/10.5021/ad.2016.28.4.444
|
|
| 10 |
Correlation between Drug Market Withdrawals and Socioeconomic, Health, and Welfare Indicators Worldwide
Kye Hwa Lee, Grace Juyun Kim, Ju Han Kim
|
|
